NIPAL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.288800E-01
Normal-vs-Stage2
8.269400E-01
Normal-vs-Stage3
9.527500E-02
Normal-vs-Stage4
3.663000E-01
Stage1-vs-Stage2
3.943000E-01
Stage1-vs-Stage3
3.673600E-02
Stage1-vs-Stage4
5.712000E-01
Stage2-vs-Stage3
1.016590E-01
Stage2-vs-Stage4
1.235610E-01
Stage3-vs-Stage4
1.247610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.003000E-01
Normal-vs-AfricanAmerican
7.918800E-01
Normal-vs-Asian
8.642400E-01
Caucasian-vs-AfricanAmerican
8.171000E-01
Caucasian-vs-Asian
8.484600E-01
AfricanAmerican-vs-Asian
9.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.244600E-01
Normal-vs-Female
9.021600E-01
Male-vs-Female
7.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.597400E-01
Normal-vs-Age(41-60Yrs)
6.290000E-01
Normal-vs-Age(61-80Yrs)
9.621400E-01
Normal-vs-Age(81-100Yrs)
8.745200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.671000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.965400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.367600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.188810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.391000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.467000E-01
Normal-vs-Daily Drinker
7.795600E-01
Normal-vs-Weekly Drinker
8.821200E-01
Normal-vs-Occasional Drinker
5.813000E-01
Normal-vs-Social Drinker
7.883400E-01
Non Drinker-vs-Daily Drinker
3.074200E-01
Non Drinker-vs-Weekly Drinker
5.168400E-01
Non Drinker-vs-Occasional Drinker
3.929800E-01
Non Drinker-vs-Social Drinker
8.936600E-01
Daily Drinker-vs-Weekly Drinker
8.729800E-01
Daily Drinker-vs-Occasional Drinker
1.213580E-01
Daily Drinker-vs-Social Drinker
3.360600E-01
Weekly Drinker-vs-Occasional Drinker
2.636600E-01
Weekly Drinker-vs-Social Drinker
5.254800E-01
Occasional Drinker-vs-Social Drinker
5.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.034800E-01
Normal-vs-Grade 2
1.987930E-02
Normal-vs-Grade 3
2.192200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.905200E-01
Grade 1-vs-Grade 3
1.303190E-01
Grade 1-vs-Grade 4
1.034800E-01
Grade 2-vs-Grade 3
2.282800E-01
Grade 2-vs-Grade 4
1.987930E-02
Grade 3-vs-Grade 4
2.192200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.497800E-01
Normal-vs-NonDiabetic
9.803600E-01
Diabetic-vs-NonDiabetic
7.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.085200E-01
Normal-vs-NoPancreatitis
9.590600E-01
Pancreatitis-vs-NoPancreatitis
8.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.086800E-01
Normal-vs-N1
8.220400E-01
N0-vs-N1
7.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.699800E-01
Normal-vs-TP53-NonMutant
6.046400E-01
TP53-Mutant-vs-TP53-NonMutant
4.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
